Related Experiment Video
Updated: May 26, 2025

Methodology for Biomimetic Chemical Neuromodulation of Rat Retinas with the Neurotransmitter Glutamate In Vitro
Published on: December 19, 2017
Artificial intelligence in managing retinal disease-current concepts and relevant aspects for health care providers
Sophie Riedl1, Klaudia Birner1, Ursula Schmidt-Erfurth2
1Department of Ophthalmology and Optometry, Laboratory of Ophthalmic Image Analysis, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.
Abstract:
Given how the diagnosis and management of many ocular and, most specifically, retinal diseases heavily rely on various imaging modalities, the introduction of artificial intelligence (AI) into this field has been a logical, inevitable, and successful development in recent decades. The field of retinal diseases has practically become a showcase for the use of AI in medicine. In this article, after providing a short overview of the most relevant retinal diseases and their socioeconomic impact, we highlight various aspects of how AI can be applied in research, diagnosis, and disease management and how this is expected to alter patient flows, affecting also health care professionals beyond ophthalmologists.
Related Concept Videos
The Retina
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...

